Joel Isaacson & Co’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-48
Closed -$2K 441
2016
Q4
$2K Hold
48
﹤0.01% 614
2016
Q3
$3K Hold
48
﹤0.01% 652
2016
Q2
$2K Hold
48
﹤0.01% 677
2016
Q1
$2K Hold
48
﹤0.01% 733
2015
Q4
$3K Sell
48
-1
-2% -$60 ﹤0.01% 663
2015
Q3
$2K Hold
49
﹤0.01% 682
2015
Q2
$3K Buy
49
+1
+2% +$39 ﹤0.01% 691
2015
Q1
$2K Hold
48
﹤0.01% 657
2014
Q4
$1K Hold
48
﹤0.01% 616
2014
Q3
$1K Hold
48
﹤0.01% 597
2014
Q2
$1K Hold
48
﹤0.01% 564
2014
Q1
$2K Hold
48
﹤0.01% 540
2013
Q4
$1K Buy
+48
New +$1.2K ﹤0.01% 499

Other funds holding PRTA

Joel Isaacson & Co's PRTA Position: Q1 2017 in Review

Joel Isaacson & Co sold out of Prothena Corp (PRTA) in Q1 2017, closing a stake of 48 shares — an estimated $2K sold.

Joel Isaacson & Co first reported a position in PRTA in Q4 2013 and held it in 13 quarters. The position peaked at $3K in Q3 2016. 146 funds tracked by Wall St. Rank hold PRTA as of Q1 2017.

  • Joel Isaacson & Co reported no remaining Prothena Corp position as of Q1 2017 after selling out during the quarter.
  • Joel Isaacson & Co sold 48 Prothena Corp shares in Q1 2017, an estimated $2K.
  • Joel Isaacson & Co first reported a position in Prothena Corp in Q4 2013 and held it in 13 quarters.
  • Joel Isaacson & Co's Prothena Corp position peaked at $3K in Q3 2016.
  • 146 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2017.

Based on Joel Isaacson & Co's 13F filing for Q1 2017, filed 5 May 2017.